ONCBeOne Medicines AG
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Price is +10% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 9, 2026; selling is often routine (taxes, diversification).
Lightly shorted, settled Sep 30, 2026, about a week of normal trading to cover. Up 13% since the previous count, up from 1.0% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ONC is trading
BeOne Medicines AG is +5.9% over the past year while the S&P 500 is +18%: 12 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +10%
vs 200-day average · a clear uptrend
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 6.1%
Below its 52-week high
Details›
- Last close2026-10-09
- $354.29
- 1 monthS&P 500 +2.7%
- +3.7%
- 1 yearS&P 500 +18%
- +5.9%
- 5 yearsS&P 500 +88%
- −4.0%
- vs 50-day average$355.92
- −0.46%
- 52-week high
- $377.47
- 52-week low
- $260.27
- Annualised volatility
- 43%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-09
- −$8.2M
| Year | Return |
|---|---|
| 2026 (year to date) | +17% |
| 2025 | +64% |
| 2024 | +2.4% |
| 2023 | −18% |
| 2022 | −19% |
| 2021 | +4.9% |
| 2020 | +56% |
| 2019 | +18% |
| 2018 | +44% |
| 2017 | +222% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +8.4% |
| Feb | 10 | 6 of 10 | +2.8% |
| Mar | 10 | 3 of 10 | −3.2% |
| Apr | 10 | 4 of 10 | +2.6% |
| May | 10 | 3 of 10 | −2.3% |
| Jun | 10 | 4 of 10 | +0.26% |
| Jul | 11 | 9 of 11 | +15% |
| Aug | 11 | 7 of 11 | +3.9% |
| Sep | 11 | 7 of 11 | +6.5% |
| Oct | 11 | 5 of 11 | −0.70% |
| Nov | 10 | 6 of 10 | +6.4% |
| Dec | 10 | 3 of 10 | −4.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry